Superpower.

What Superpower actually is

The most aggressively priced direct-to-consumer biomarker membership currently in market. $349 a year buys 150+ lab tests across two blood draws — a 100+ marker baseline and a 50+ marker retest — plus a personalised AI-driven action plan and access to a care team. It is, in business-model terms, a mass-market version of Function Health: same proposition, slightly cheaper, lighter clinical wrapper, and now a marketplace on top.

The proposition is access. Biomarker testing has historically been gated by clinical relationship, by insurance contracts, and by the executive-medicine pricing structure. Superpower is part of a category move to commodity-price the bloodwork itself. We credit the directional shift even where we have specific reservations about this implementation.

What you get

A 100+ marker annual panel covering cardiovascular, metabolic, hormonal, inflammation, biological-age, and several specialist axes. An AI-driven dashboard that scores results, flags anomalies, and generates a personalised protocol — lifestyle, supplementation suggestions, retesting schedule. A 24/7 chat care team for questions on results.

The 50+ marker retest is included. Add-on panels (gut health, environmental toxins, the Galleri multi-cancer test) cost extra; their prices are not published. Members can also access prescriptions, peptides and supplements through the Superpower marketplace.

Where it does not equal a clinical relationship

Three honest reservations.

Care depth. The 24/7 chat care team is a useful asset but is not, in our reading, a substitute for the structured physician relationship the upper-tier clinics provide. The first responder may not be a physician; the response time is fast but the depth is constrained by chat as a medium and by the need to scale across thousands of members.

AI-driven protocol generation. This is positioned as a personalisation feature. The underlying claim — that AI-prescribed lifestyle protocols outperform a thoughtful generalist clinician’s design — has very limited published evidence in healthspan outcomes. The protocol is internally consistent; whether it is clinically superior to the same advice from a doctor is an open question.

The marketplace. Superpower now sells prescriptions, peptides and supplements to its members; press reports since early 2026 include GLP-1 peptides. The platform that reads your bloodwork also sells the response to it. That is the diagnose-then-sell geometry we deduct for elsewhere in this directory, delivered at consumer scale.

Where Superpower sits

For a specific reader profile, Superpower is the right purchase: someone in the early stages of engaging with personal health data, on a tight budget, willing to do the interpretive work themselves, and not yet ready to commit to a clinical relationship.

For that reader, $349 buys a usable annual baseline that did not exist at this price two years ago. We rate the proposition fairly.

For the reader who wants clinician-led longitudinal care, who wants imaging in the workup, who wants the depth that decides borderline findings — Superpower is a substantially lighter product than the rest of the directory. It is honest about being lighter; the marketing copy occasionally is not.

The verdict

Cheap, scaled, no longer clean on the conflict question now that the marketplace sells treatments, and structurally light on the medical-supervision question. A useful market entrant rather than a clinical destination.

A $349 product cannot be the same as a $23,500 product. Both can be honest about what they are; the rest is reader judgement.

Questions readers ask about Superpower

— 01

How much does Superpower cost?

Pricing for Superpower, as checked in September 2026: Annual membership at $349 per year.

— 02

Does Superpower earn from the treatments it recommends?

Yes. We score this as a structural conflict of interest. Membership-and-bloodwork model with a marketplace on top: members can access prescriptions, peptides and supplements, recommended by the same AI and care team that reads their bloodwork. Superpower scores 14/25 on conflict freedom.

— 03

Is Superpower physician-led?

Not in the clinical sense our rubric requires. Medical leadership: Dr. Anant Vinjamoori, MD (Chief Longevity Officer), with a medical advisory board. Superpower scores 12/25 on medical supervision.

— 04

How does Superpower rank among longevity clinics?

Superpower ranks #19 of 19 in the 2026 Longevity Clinics ranking, with 57/100 (Mixed). Cheap. Not equivalent to clinician-led care. Clear about what it is, less clear about what it is not.